Repligen Corp. Files 2024 Annual Report
Ticker: RGEN · Form: 10-K · Filed: Mar 14, 2025 · CIK: 730272
| Field | Detail |
|---|---|
| Company | Repligen Corp (RGEN) |
| Form Type | 10-K |
| Filed Date | Mar 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, financials, biotech
TL;DR
Repligen's 2024 10-K is in: full financial picture for the year ending Dec 31.
AI Summary
Repligen Corp. filed its 10-K for the fiscal year ending December 31, 2024, detailing its financial performance and business operations. The company, headquartered in Waltham, MA, operates in the biological products sector. Key financial data and operational highlights for 2024 are presented in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Repligen's financial health, strategic initiatives, and risks for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — The filing contains standard disclosures for a public company, including financial performance, operational risks, and forward-looking statements, which inherently carry risk.
Key Numbers
- 364 — FY (Fiscal Year)
- 365 — Days (Fiscal Year)
- 351 — Days (Fiscal Year)
Key Players & Entities
- REPLIGEN CORP (company) — Filer
- WALTHAM, MA (location) — Business Address
- 2024-12-31 (date) — Fiscal Year End
- Flexbiosys Inc (company) — Mentioned in context of 2023-12-31
- Metenova Holding Ab (company) — Mentioned in context of Developed Technology
FAQ
What were Repligen's total revenues for the fiscal year ending December 31, 2024?
The filing does not explicitly state the total revenue figure in the provided snippet, but it does reference financial data for the fiscal year ending December 31, 2024.
What is Repligen Corp's Standard Industrial Classification code?
Repligen Corp's Standard Industrial Classification code is 2836, categorized under Biological Products (No Diagnostic Substances).
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 14, 2025.
What is the company's state of incorporation?
Repligen Corp. is incorporated in Delaware (DE).
Are there any convertible senior notes mentioned in the filing?
Yes, the filing mentions 'Zero Point Three Seven Five Percent Convertible Senior Notes Due Twenty Twenty Four' in the context of an exchange transaction.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 14, 2025 regarding REPLIGEN CORP (RGEN).